insights_auto
Why is ACAD up 3.38%?
Dive Deeperchevron_right
ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$19.25
arrow_upward
+3.38%(+0.63) 1D
$19.25
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 14, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$18.60
High
$19.28
Low
$18.49
Mkt. cap
3.32B
Avg. vol.
2.13M
Volume
1.64M
P/E ratio
8.70
52-wk high
$30.96
52-wk low
$18.39
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
Open
$18.60
High
$19.28
Low
$18.49
Mkt. cap
3.32B
Avg. vol.
2.13M
Volume
1.64M
P/E ratio
8.70
52-wk high
$30.96
52-wk low
$18.39
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
GuruFocus
·
1 day ago
ACAD Downgraded by UBS -- Price Target Lowered to $23.00
TipRanks
·
1 day ago
ACADIA Stock Slumps As UBS Slashes Drug Hopes
The Globe and Mail
·
1 day ago
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com